Sponsor
ALX Oncology Inc.
Clinical research sponsor
Clinical trials
3 shownASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast CancerNCT07007559 · lead sponsor · 2025-12-10
RECRUITINGA First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid TumorsNCT07085091 · lead sponsor · 2025-08-18
RECRUITINGPRE-ISPY Phase I/II Oncology Platform ProgramNCT05868226 · collaborator · 2023-02-15
RECRUITINGSponsor roles
lead sponsor2
collaborator1
How to interpret this record
CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.